Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher H Gottschalk

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Psychoactive Drugs|November 24, 2015
Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use SurveyEmmanuelle A D Schindler, Christopher H Gottschalk, Marsha J Weil, et al.
Headache|September 18, 2018
Survey Analysis of the Use, Effectiveness, and Patient-Reported Tolerability of Inhaled Oxygen Compared With Injectable Sumatriptan for the Acute Treatment of Cluster HeadacheEmmanuelle A D Schindler, Douglas A Wright, Marsha J Weil, et al.
Journal of the Neurological Sciences|April 6, 2024
Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 13, 2020
Exploratory Controlled Study of the Migraine-Suppressing Effects of PsilocybinEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.
Headache|November 23, 2022
Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.
Neurology|December 23, 2024
Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 TrialsRichard B Lipton, Pranav Gandhi, Cristina Tassorelli, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Psychoactive Drugs|November 24, 2015
Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use SurveyEmmanuelle A D Schindler, Christopher H Gottschalk, Marsha J Weil, et al.
Headache|September 18, 2018
Survey Analysis of the Use, Effectiveness, and Patient-Reported Tolerability of Inhaled Oxygen Compared With Injectable Sumatriptan for the Acute Treatment of Cluster HeadacheEmmanuelle A D Schindler, Douglas A Wright, Marsha J Weil, et al.
Journal of the Neurological Sciences|April 6, 2024
Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 13, 2020
Exploratory Controlled Study of the Migraine-Suppressing Effects of PsilocybinEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.
Headache|November 23, 2022
Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trialEmmanuelle A D Schindler, R Andrew Sewell, Christopher H Gottschalk, et al.
Neurology|December 23, 2024
Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 TrialsRichard B Lipton, Pranav Gandhi, Cristina Tassorelli, et al.
Pageof 2